FLEXION THERAPEUTICS INC - COM (FLXN)

CUSIP: 33938J106

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
45,129,271
Share change
-1,774,287
Total reported value
$371,371,813
Put/Call ratio
346%
Price per share
$8.23
Number of holders
135
Value change
-$18,673,690
Number of buys
77
Number of sells
58

Quarterly Holders Quick Answers

What is CUSIP 33938J106?
CUSIP 33938J106 identifies FLXN - FLEXION THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - COM (FLXN) as of Q2 2021

As of 30 Jun 2021, FLEXION THERAPEUTICS INC - COM (FLXN) was held by 135 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,129,271 shares. The largest 10 holders included BlackRock Inc., WASATCH ADVISORS INC, STATE STREET CORP, Artisan Partners Limited Partnership, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, Clearline Capital LP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Novo Holdings A/S, and GOLDMAN SACHS GROUP INC. This page lists 135 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.